NO153692C - Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2). - Google Patents

Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2).

Info

Publication number
NO153692C
NO153692C NO783143A NO783143A NO153692C NO 153692 C NO153692 C NO 153692C NO 783143 A NO783143 A NO 783143A NO 783143 A NO783143 A NO 783143A NO 153692 C NO153692 C NO 153692C
Authority
NO
Norway
Prior art keywords
type
subnuity
subness
hsv2
hsv1
Prior art date
Application number
NO783143A
Other languages
English (en)
Norwegian (no)
Other versions
NO153692B (no
NO783143L (no
Inventor
Vivian Larson
Ernest Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO783143L publication Critical patent/NO783143L/no
Publication of NO153692B publication Critical patent/NO153692B/no
Publication of NO153692C publication Critical patent/NO153692C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO783143A 1977-09-19 1978-09-18 Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2). NO153692C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83459877A 1977-09-19 1977-09-19

Publications (3)

Publication Number Publication Date
NO783143L NO783143L (no) 1979-03-20
NO153692B NO153692B (no) 1986-01-27
NO153692C true NO153692C (no) 1986-05-07

Family

ID=25267310

Family Applications (1)

Application Number Title Priority Date Filing Date
NO783143A NO153692C (no) 1977-09-19 1978-09-18 Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2).

Country Status (9)

Country Link
EP (1) EP0001365B2 (it)
JP (1) JPS5484024A (it)
CA (1) CA1114294A (it)
DE (1) DE2862086D1 (it)
DK (1) DK411878A (it)
FI (1) FI66020C (it)
IE (1) IE47364B1 (it)
IT (1) IT1110864B (it)
NO (1) NO153692C (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
CA1201987A (en) * 1982-03-24 1986-03-18 Gordon R.B. Skinner Vaccine against dna viruses
DE3378611D1 (en) * 1982-03-24 1989-01-12 Univ Birmingham Vaccine against dna viruses
US5219567A (en) * 1982-03-24 1993-06-15 The University Of Birmingham Vaccine against herpes viruses
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
DE4033446A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Impfstoffe gegen equine herpesviren und ihre herstellung
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses

Also Published As

Publication number Publication date
FI66020C (fi) 1984-08-10
FI782769A7 (fi) 1979-03-20
EP0001365A1 (en) 1979-04-04
CA1114294A (en) 1981-12-15
EP0001365B1 (en) 1982-11-10
NO153692B (no) 1986-01-27
NO783143L (no) 1979-03-20
IE781880L (en) 1979-03-19
IE47364B1 (en) 1984-03-07
EP0001365B2 (en) 1987-09-23
IT1110864B (it) 1986-01-06
DE2862086D1 (en) 1982-12-16
JPS5484024A (en) 1979-07-04
FI66020B (fi) 1984-04-30
IT7851116A0 (it) 1978-09-15
DK411878A (da) 1979-03-20

Similar Documents

Publication Publication Date Title
NO153692C (no) Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2).
NO151225C (no) Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner
CA1341645C (en) Non-passageable viruses
NO802546L (no) Fremgangsmaate ved fremstilling av beta-carbolin-3-carboxylsyre-derivater.
NO155453C (no) Fremgangsmaate ved eksternliming av papir eller kartong.
NO153011C (no) Fremgangsmaate ved fremstilling av trestatin a, b og c.
NO801796L (no) Fremgangsmaate ved fremstilling av 4-aroylimidazol-2-oner
NO154602C (no) Fremgangsmaate ved opparbeiding av vrakglass.
AU4082878A (en) Heating improvements ina preform reheat system
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
NO791845L (no) Fremgangsmaate ved fremstilling av silicium eller ferrosilicium
NO793804L (no) Fremgangsmaate ved fremstilling av slipemasse.
GB2060690B (en) Preparation of virus sub-population having increased sensitivity toward host cells for the virus
NO155477C (no) Fremgangsmaate ved fremstilling av et konsentrert protrombinkompleks.
DK333183A (da) Fremgangsmaade til fremstilling af herpes simplex virusglycoproteiner
NO152894C (no) Fremgangsmaate ved fremstilling av ureapellets.
NO822410L (no) Fremgangsmaate ved fremstilling av benzothiazolsulfonamid-derivater.
NO153431C (no) Fremgangsmaate ved fremstilling av 6alfa-halogen-3-keto-delta1,4-pregnadiener.
NO154584C (no) Fremgangsmaate for fremstilling av 3-0-(beta-d-glucuronpyrasyl) soyasapogenol b.
NO900873D0 (no) Fremgangsmaate ved fremstilling av sekundaert alkylamin.
IL58947A (en) Vaccines against viral illnesses
NO802324L (no) Fremgangsmaate ved fremstilling av 3-amino-1-benzoxepin-5(2h)-derivater.
NO154837C (no) Fremgangsmaate ved fremstilling av 7-acylindolin-2-oner.
NO154347C (no) Fremgangsmaate ved fremstilling av melamin.
NO157063C (no) FremgangsmŸte for fremstilling av etylen-propylen-blokk-sampolymerer.